Clinical Trials
29 trialsE-FACTOR
Centre Leon Berard
ECHO
Mayo Clinic
OvBIOMark
Gustave Roussy, Cancer Campus, Grand Paris
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
Wake Forest University Health Sciences
PARIB-OLD-PRO²
Hospices Civils de Lyon
SPEED
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
Massachusetts General Hospital
DECIDE
Institut Claudius Regaud
GYNO-MIR
Assistance Publique - Hôpitaux de Paris
Assessment of Paclitaxel-Induced Neuropathy
University of Chicago
EXODIAG
Centre Georges Francois Leclerc
PROGENITOR
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
PICTURE
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
MR-O-MICS
Institut du Cancer de Montpellier - Val d'Aurelle
Liquid Biopsy-based Early Detection of Ovarian Cancer: a Proof-of-concept Study ( PROFOUND-OC )
Fudan University
Study of Circulating Tumoral DNA in Ovarian Cancer
Institut Curie
IMMUNOPARP
Centre Georges Francois Leclerc
EMBER
Angle plc
Establishment of a Tumor Bank for Blood Samples
Medical University of Vienna
Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer
H. Lee Moffitt Cancer Center and Research Institute
ADOPT
University of Dundee
ONCOPRO
Hospices Civils de Lyon
Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by Culdocentesis
Dana-Farber Cancer Institute
BEDOCA
Sheba Medical Center
Evaluation of Multiple Biomarkers to Estimate Risk of Ovarian Cancer in Patients With a Pelvic Mass.
Angle plc
miRSa
Centre Francois Baclesse
Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity
PX Biosolutions
EXSAL
Centre Francois Baclesse
Assess Cancer in Ovarian Tumors With Biomarkers.
Ciphergen Biosystems